dephostatin has been researched along with Lymphoma, Non-Hodgkin in 1 studies
dephostatin: from Streptomyces sp. MJ742-NF5; structure given in first source
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Donnell, RT | 1 |
| Pearson, D | 1 |
| McKnight, HC | 1 |
| Ma, YP | 1 |
| Tuscano, JM | 1 |
1 other study available for dephostatin and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Phosphatase inhibition augments anti-CD22-mediated signaling and cytotoxicity in non-hodgkin's lymphoma cells.
Topics: Antibodies, Monoclonal; Apoptosis; Cell Line, Tumor; Enzyme Activation; Flow Cytometry; Genes, Domin | 2009 |